- Previous Close
1.880 - Open
1.870 - Bid 1.870 x --
- Ask 1.900 x --
- Day's Range
1.860 - 1.900 - 52 Week Range
1.800 - 2.680 - Volume
68,000 - Avg. Volume
114,559 - Market Cap (intraday)
3.328B - Beta (5Y Monthly) 0.24
- PE Ratio (TTM)
23.38 - EPS (TTM)
0.080 - Earnings Date --
- Forward Dividend & Yield 0.05 (2.66%)
- Ex-Dividend Date Jun 4, 2024
- 1y Target Est
2.56
Ausnutria Dairy Corporation Ltd, an investment holding company, primarily engages in the research and development, production, marketing, processing, packaging, and distribution of dairy and related products, and nutrition products. The company operates in two segments, Dairy and Related Products, and Nutrition Products. It offers cow and goat-based milk formula products for infants. The company also engages in the marketing and distribution of goat milk nutrition products; and research and development, distribution, manufacturing, and sale of probiotic products, and related fermentation-related products. It offers its products under the Hyproca 1897, Kabrita, Allnutria, Youzhuang, Neolac, Augood, Oz Farm, AUNULIFE, and NC brand names. The company operates in the People's Republic of China, the European Union, Southeast Asia, Australia, New Zealand, the Middle East, North and South America, and internationally. The company was founded in 2003 and is based in Sheung Wan, Hong Kong. Ausnutria Dairy Corporation Ltd operates as a subsidiary of HongKong Jingang Trade Holding Company Limited.
www.ausnutria.com.hk3,474
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 1717.HK
View MorePerformance Overview: 1717.HK
Trailing total returns as of 2/25/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 1717.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 1717.HK
View MoreValuation Measures
Market Cap
3.35B
Enterprise Value
3.66B
Trailing P/E
23.02
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.42
Price/Book (mrq)
0.54
Enterprise Value/Revenue
0.45
Enterprise Value/EBITDA
16.71
Financial Highlights
Profitability and Income Statement
Profit Margin
1.79%
Return on Assets (ttm)
1.70%
Return on Equity (ttm)
2.43%
Revenue (ttm)
7.55B
Net Income Avi to Common (ttm)
135.18M
Diluted EPS (ttm)
0.080
Balance Sheet and Cash Flow
Total Cash (mrq)
2.19B
Total Debt/Equity (mrq)
42.71%
Levered Free Cash Flow (ttm)
225.2M